Saltar al contenido
Merck

Diverse intracellular pathogens activate type III interferon expression from peroxisomes.

Nature immunology (2014-06-24)
Charlotte Odendall, Evelyn Dixit, Fabrizia Stavru, Helene Bierne, Kate M Franz, Ann Fiegen Durbin, Steeve Boulant, Lee Gehrke, Pascale Cossart, Jonathan C Kagan
RESUMEN

Type I interferon responses are considered the primary means by which viral infections are controlled in mammals. Despite this view, several pathogens activate antiviral responses in the absence of type I interferons. The mechanisms controlling type I interferon-independent responses are undefined. We found that RIG-I like receptors (RLRs) induce type III interferon expression in a variety of human cell types, and identified factors that differentially regulate expression of type I and type III interferons. We identified peroxisomes as a primary site of initiation of type III interferon expression, and revealed that the process of intestinal epithelial cell differentiation upregulates peroxisome biogenesis and promotes robust type III interferon responses in human cells. These findings highlight the importance of different intracellular organelles in specific innate immune responses.

MATERIALES
Referencia del producto
Marca
Descripción del producto

Sigma-Aldrich
Anti-β-actina monoclonal antibody produced in mouse, clone AC-15, ascites fluid
Sigma-Aldrich
Anti-α-tubulina monoclonal antibody produced in mouse, clone B-5-1-2, purified from hybridoma cell culture
Sigma-Aldrich
Anti-PMP70 antibody, Mouse monoclonal, clone 70-18, purified from hybridoma cell culture
Sigma-Aldrich
MISSION® esiRNA, targeting mouse Mavs
Sigma-Aldrich
MISSION® esiRNA, targeting human IRF3